HomeCompareCEOS vs XYLD

CEOS vs XYLD: Dividend Comparison 2026

CEOS yields 76923.08% · XYLD yields 11.20%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CEOS wins by $3.5207463509675137e+25M in total portfolio value
10 years
CEOS
CEOS
● Live price
76923.08%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3.5207463509675137e+25M
Annual income
$35,117,657,238,443,270,000,000,000,000,000.00
Full CEOS calculator →
XYLD
Global X S&P 500 Covered Call ETF
● Live price
11.20%
Share price
$38.36
Annual div
$4.30
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.9K
Annual income
$3,351.03
Full XYLD calculator →

Portfolio growth — CEOS vs XYLD

📍 CEOS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCEOSXYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CEOS + XYLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CEOS pays
XYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CEOS
Annual income on $10K today (after 15% tax)
$6,538,461.54/yr
After 10yr DRIP, annual income (after tax)
$29,850,008,652,676,780,000,000,000,000,000.00/yr
XYLD
Annual income on $10K today (after 15% tax)
$952.37/yr
After 10yr DRIP, annual income (after tax)
$2,848.38/yr
At 15% tax rate, CEOS beats the other by $29,850,008,652,676,780,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CEOS + XYLD for your $10,000?

CEOS: 50%XYLD: 50%
100% XYLD50/50100% CEOS
Portfolio after 10yr
$1.7603731754837569e+25M
Annual income
$17,558,828,619,221,635,000,000,000,000,000.00/yr
Blended yield
99.74%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CEOS buys
0
XYLD buys
0
No recent congressional trades found for CEOS or XYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCEOSXYLD
Forward yield76923.08%11.20%
Annual dividend / share$2.00$4.30
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$3.5207463509675137e+25M$25.9K
Annual income after 10y$35,117,657,238,443,270,000,000,000,000,000.00$3,351.03
Total dividends collected$3.520157521397876e+25M$20.2K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: CEOS vs XYLD ($10,000, DRIP)

YearCEOS PortfolioCEOS Income/yrXYLD PortfolioXYLD Income/yrGap
1← crossover$7,703,008$7,692,307.69$10,840$1,120.44+$7.69MCEOS
2$5,545,990,379$5,537,748,161.26$11,786$1,249.59+$5545.98MCEOS
3$3,732,151,735,917$3,726,217,526,211.36$12,854$1,397.78+$3732151.72MCEOS
4$2,347,491,508,714,269$2,343,498,106,356,837.00$14,063$1,568.33+$2347491508.70MCEOS
5$1,380,119,533,083,814,100$1,377,607,717,169,489,700.00$15,434$1,765.19+$1380119533083.80MCEOS
6$758,404,537,995,947,800,000$756,927,810,095,548,100,000.00$16,995$1,993.14+$758404537995947.75MCEOS
7$389,547,620,856,236,000,000,000$388,736,128,000,580,400,000,000.00$18,777$2,257.95+$389547620856236032.00MCEOS
8$187,025,031,600,452,680,000,000,000$186,608,215,646,136,520,000,000,000.00$20,818$2,566.58+$187025031600452665344.00MCEOS
9$83,931,094,609,218,200,000,000,000,000$83,730,977,825,405,720,000,000,000,000.00$23,163$2,927.50+$8.39310946092182e+22MCEOS
10$35,207,463,509,675,137,000,000,000,000,000$35,117,657,238,443,270,000,000,000,000,000.00$25,865$3,351.03+$3.5207463509675137e+25MCEOS

CEOS vs XYLD: Complete Analysis 2026

CEOSStock

Psykey, Inc. engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines to improve and optimize life. The company also engages in the development of technologies for the composition, bioavailability, and targeted delivery of entheogen-based therapeutics for the psychedelic market. Its retail products include functional mushroom coffees and teas, oral supplements, and single serve drink mixes. The company was formerly known as CeCors, Inc. and changed its name to Psykey, Inc. in August 2021. Psykey, Inc. was founded in 2002 and is based in Toronto, Canada.

Full CEOS Calculator →

XYLDETF

The Global X S&P 500 Covered Call ETF (XYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe S&P 500 BuyWrite Index.

Full XYLD Calculator →
📬

Get this CEOS vs XYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CEOS vs SCHDCEOS vs JEPICEOS vs OCEOS vs KOCEOS vs MAINCEOS vs QYLDCEOS vs JEPQCEOS vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.